Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3

V. Liakina; S. Hamid; J. Tanaka; S. Olafsson; A. I. Sharara; S. M. Alavian; L. Gheorghe; E. S. El Hassan; F. Abaalkhail; Z. Abbas; A. Abdou; A. Abourached; F. Al Braiki; F. Al Hosani; K. Al Jaberi; M. Al Khatry; M. A. Al Mulla; H. Al Quraishi; A. Al Rifai; Y. Al Serkal; A. Alam; H. I. Alashgar; S. Alawadhi; L. Al-Dabal; P. Aldins; F. Z. Alfaleh; A. S. Alghamdi; R. Al-Hakeem; A. A. Aljumah; A. Almessabi; A. N. Alqutub; K. A. Alswat; I. Altraif; M. Alzaabi; N. Andrea; A. M. Assiri; M. A. Babatin; A. Baqir; M. T. Barakat; O. M. Bergmann; A. R. Bizri; S. Blach; A. Chaudhry; M. S. Choi; T. Diab; S. Djauzi; S. El Khoury; C. Estes; S. Fakhry; J. I. Farooqi; H. Fridjonsdottir; R. A. Gani; A. Ghafoor Khan; A. Goldis; M. Gottfredsson; S. Gregorcic; B. Hajarizadeh; K. H. Han; I. Hasan; A. Hashim; G. Horvath; B. Hunyady; R. Husni; W. Jafri; A. Jeruma; J. G. Jonasson; B. Karlsdottir; D. Y. Kim; Y. S. Kim; Z. Koutoubi; L. A. Lesmana; Y. S. Lim; A. Löve; M. Maimets; M. Makara; R. Malekzadeh; M. Matičič; M. S. Memon; S. Merat; J. E. Mokhbat; F. H. Mourad; D. H. Muljono; A. Nawaz; N. Nugrahini; S. Priohutomo; H. Qureshi; P. Rassam; H. Razavi; D. Razavi-Shearer; K. Razavi-Shearer; B. Rozentale; M. Sadik; K. Saeed; A. Salamat; R. Salupere; F. M. Sanai; A. Sanityoso Sulaiman; R. A. Sayegh; J. D. Schmelzer; A. Sibley; M. Siddiq; A. M. Siddiqui; G. Sigmundsdottir; B. Sigurdardottir; D. Speiciene; A. Sulaiman; M. A. Sultan; M. Taha; H. Tarifi; G. Tayyab; I. Tolmane; M. Ud Din; M. Umar; J. Valantinas; J. Videčnik-Zorman; C. Yaghi; E. Yunihastuti; M. A. Yusuf; B. F. Zuberi; J. Gunter

doi:10.1111/jvh.12475

Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3

V. Liakina, S. Hamid, J. Tanaka, S. Olafsson, A. I. Sharara, S. M. Alavian, L. Gheorghe, E. S. El Hassan, F. Abaalkhail, Z. Abbas, A. Abdou, A. Abourached, F. Al Braiki, F. Al Hosani, K. Al Jaberi, M. Al Khatry, M. A. Al Mulla, H. Al Quraishi, A. Al Rifai, Y. Al SerkalA. Alam, H. I. Alashgar, S. Alawadhi, L. Al-Dabal, P. Aldins, F. Z. Alfaleh, A. S. Alghamdi, R. Al-Hakeem, A. A. Aljumah, A. Almessabi, A. N. Alqutub, K. A. Alswat, I. Altraif, M. Alzaabi, N. Andrea, A. M. Assiri, M. A. Babatin, A. Baqir, M. T. Barakat, O. M. Bergmann, A. R. Bizri, S. Blach, A. Chaudhry, M. S. Choi, T. Diab, S. Djauzi, S. El Khoury, C. Estes, S. Fakhry, J. I. Farooqi, H. Fridjonsdottir, R. A. Gani, A. Ghafoor Khan, A. Goldis, M. Gottfredsson, S. Gregorcic, B. Hajarizadeh, K. H. Han, I. Hasan, A. Hashim, G. Horvath, B. Hunyady, R. Husni, W. Jafri, A. Jeruma, J. G. Jonasson, B. Karlsdottir, D. Y. Kim, Y. S. Kim, Z. Koutoubi, L. A. Lesmana, Y. S. Lim, A. Löve, M. Maimets, M. Makara, R. Malekzadeh, M. Matičič, M. S. Memon, S. Merat, J. E. Mokhbat, F. H. Mourad, D. H. Muljono, A. Nawaz, N. Nugrahini, S. Priohutomo, H. Qureshi, P. Rassam, H. Razavi, D. Razavi-Shearer, K. Razavi-Shearer, B. Rozentale, M. Sadik, K. Saeed, A. Salamat, R. Salupere, F. M. Sanai, A. Sanityoso Sulaiman, R. A. Sayegh, J. D. Schmelzer, A. Sibley, M. Siddiq, A. M. Siddiqui, G. Sigmundsdottir, B. Sigurdardottir, D. Speiciene, A. Sulaiman, M. A. Sultan, M. Taha, H. Tarifi, G. Tayyab, I. Tolmane, M. Ud Din, M. Umar, J. Valantinas, J. Videčnik-Zorman, C. Yaghi, E. Yunihastuti, M. A. Yusuf, B. F. Zuberi, J. Gunter

Department of Medicine, Medical College, Pakistan

Research output: Contribution to journal › Article › peer-review

76 Citations (Scopus)

Abstract

Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.

Original language	English
Pages (from-to)	4-20
Number of pages	17
Journal	Journal of Viral Hepatitis
Volume	22
DOIs	https://doi.org/10.1111/jvh.12475
Publication status	Published - Dec 2015

Keywords

diagnosis
disease burden
epidemiology
hepatitis C
hepatitis C virus
historical
incidence
mortality
prevalence
treatment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jvh.12475

Cite this

Liakina, V., Hamid, S., Tanaka, J., Olafsson, S., Sharara, A. I., Alavian, S. M., Gheorghe, L., El Hassan, E. S., Abaalkhail, F., Abbas, Z., Abdou, A., Abourached, A., Al Braiki, F., Al Hosani, F., Al Jaberi, K., Al Khatry, M., Al Mulla, M. A., Al Quraishi, H., Al Rifai, A., ... Gunter, J. (2015). Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3. Journal of Viral Hepatitis, 22, 4-20. https://doi.org/10.1111/jvh.12475

@article{6e630088713d476f84166696b3147f0e,

title = "Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3",

abstract = "Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.",

keywords = "diagnosis, disease burden, epidemiology, hepatitis C, hepatitis C virus, historical, incidence, mortality, prevalence, treatment",

author = "V. Liakina and S. Hamid and J. Tanaka and S. Olafsson and Sharara, {A. I.} and Alavian, {S. M.} and L. Gheorghe and {El Hassan}, {E. S.} and F. Abaalkhail and Z. Abbas and A. Abdou and A. Abourached and {Al Braiki}, F. and {Al Hosani}, F. and {Al Jaberi}, K. and {Al Khatry}, M. and {Al Mulla}, {M. A.} and {Al Quraishi}, H. and {Al Rifai}, A. and {Al Serkal}, Y. and A. Alam and Alashgar, {H. I.} and S. Alawadhi and L. Al-Dabal and P. Aldins and Alfaleh, {F. Z.} and Alghamdi, {A. S.} and R. Al-Hakeem and Aljumah, {A. A.} and A. Almessabi and Alqutub, {A. N.} and Alswat, {K. A.} and I. Altraif and M. Alzaabi and N. Andrea and Assiri, {A. M.} and Babatin, {M. A.} and A. Baqir and Barakat, {M. T.} and Bergmann, {O. M.} and Bizri, {A. R.} and S. Blach and A. Chaudhry and Choi, {M. S.} and T. Diab and S. Djauzi and {El Khoury}, S. and C. Estes and S. Fakhry and Farooqi, {J. I.} and H. Fridjonsdottir and Gani, {R. A.} and {Ghafoor Khan}, A. and A. Goldis and M. Gottfredsson and S. Gregorcic and B. Hajarizadeh and Han, {K. H.} and I. Hasan and A. Hashim and G. Horvath and B. Hunyady and R. Husni and W. Jafri and A. Jeruma and Jonasson, {J. G.} and B. Karlsdottir and Kim, {D. Y.} and Kim, {Y. S.} and Z. Koutoubi and Lesmana, {L. A.} and Lim, {Y. S.} and A. L{\"o}ve and M. Maimets and M. Makara and R. Malekzadeh and M. Mati{\v c}i{\v c} and Memon, {M. S.} and S. Merat and Mokhbat, {J. E.} and Mourad, {F. H.} and Muljono, {D. H.} and A. Nawaz and N. Nugrahini and S. Priohutomo and H. Qureshi and P. Rassam and H. Razavi and D. Razavi-Shearer and K. Razavi-Shearer and B. Rozentale and M. Sadik and K. Saeed and A. Salamat and R. Salupere and Sanai, {F. M.} and {Sanityoso Sulaiman}, A. and Sayegh, {R. A.} and Schmelzer, {J. D.} and A. Sibley and M. Siddiq and Siddiqui, {A. M.} and G. Sigmundsdottir and B. Sigurdardottir and D. Speiciene and A. Sulaiman and Sultan, {M. A.} and M. Taha and H. Tarifi and G. Tayyab and I. Tolmane and {Ud Din}, M. and M. Umar and J. Valantinas and J. Vide{\v c}nik-Zorman and C. Yaghi and E. Yunihastuti and Yusuf, {M. A.} and Zuberi, {B. F.} and J. Gunter",

note = "Publisher Copyright: {\textcopyright} 2015 John Wiley & Sons Ltd.",

year = "2015",

month = dec,

doi = "10.1111/jvh.12475",

language = "English",

volume = "22",

pages = "4--20",

journal = "Journal of Viral Hepatitis",

issn = "1352-0504",

publisher = "Wiley-Blackwell Publishing Ltd",

}

Liakina, V, Hamid, S, Tanaka, J, Olafsson, S, Sharara, AI, Alavian, SM, Gheorghe, L, El Hassan, ES, Abaalkhail, F, Abbas, Z, Abdou, A, Abourached, A, Al Braiki, F, Al Hosani, F, Al Jaberi, K, Al Khatry, M, Al Mulla, MA, Al Quraishi, H, Al Rifai, A, Al Serkal, Y, Alam, A, Alashgar, HI, Alawadhi, S, Al-Dabal, L, Aldins, P, Alfaleh, FZ, Alghamdi, AS, Al-Hakeem, R, Aljumah, AA, Almessabi, A, Alqutub, AN, Alswat, KA, Altraif, I, Alzaabi, M, Andrea, N, Assiri, AM, Babatin, MA, Baqir, A, Barakat, MT, Bergmann, OM, Bizri, AR, Blach, S, Chaudhry, A, Choi, MS, Diab, T, Djauzi, S, El Khoury, S, Estes, C, Fakhry, S, Farooqi, JI, Fridjonsdottir, H, Gani, RA, Ghafoor Khan, A, Goldis, A, Gottfredsson, M, Gregorcic, S, Hajarizadeh, B, Han, KH, Hasan, I, Hashim, A, Horvath, G, Hunyady, B, Husni, R, Jafri, W, Jeruma, A, Jonasson, JG, Karlsdottir, B, Kim, DY, Kim, YS, Koutoubi, Z, Lesmana, LA, Lim, YS, Löve, A, Maimets, M, Makara, M, Malekzadeh, R, Matičič, M, Memon, MS, Merat, S, Mokhbat, JE, Mourad, FH, Muljono, DH, Nawaz, A, Nugrahini, N, Priohutomo, S, Qureshi, H, Rassam, P, Razavi, H, Razavi-Shearer, D, Razavi-Shearer, K, Rozentale, B, Sadik, M, Saeed, K, Salamat, A, Salupere, R, Sanai, FM, Sanityoso Sulaiman, A, Sayegh, RA, Schmelzer, JD, Sibley, A, Siddiq, M, Siddiqui, AM, Sigmundsdottir, G, Sigurdardottir, B, Speiciene, D, Sulaiman, A, Sultan, MA, Taha, M, Tarifi, H, Tayyab, G, Tolmane, I, Ud Din, M, Umar, M, Valantinas, J, Videčnik-Zorman, J, Yaghi, C, Yunihastuti, E, Yusuf, MA, Zuberi, BF & Gunter, J 2015, 'Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3', Journal of Viral Hepatitis, vol. 22, pp. 4-20. https://doi.org/10.1111/jvh.12475

TY - JOUR

T1 - Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3

AU - Liakina, V.

AU - Hamid, S.

AU - Tanaka, J.

AU - Olafsson, S.

AU - Sharara, A. I.

AU - Alavian, S. M.

AU - Gheorghe, L.

AU - El Hassan, E. S.

AU - Abaalkhail, F.

AU - Abbas, Z.

AU - Abdou, A.

AU - Abourached, A.

AU - Al Braiki, F.

AU - Al Hosani, F.

AU - Al Jaberi, K.

AU - Al Khatry, M.

AU - Al Mulla, M. A.

AU - Al Quraishi, H.

AU - Al Rifai, A.

AU - Al Serkal, Y.

AU - Alam, A.

AU - Alashgar, H. I.

AU - Alawadhi, S.

AU - Al-Dabal, L.

AU - Aldins, P.

AU - Alfaleh, F. Z.

AU - Alghamdi, A. S.

AU - Al-Hakeem, R.

AU - Aljumah, A. A.

AU - Almessabi, A.

AU - Alqutub, A. N.

AU - Alswat, K. A.

AU - Altraif, I.

AU - Alzaabi, M.

AU - Andrea, N.

AU - Assiri, A. M.

AU - Babatin, M. A.

AU - Baqir, A.

AU - Barakat, M. T.

AU - Bergmann, O. M.

AU - Bizri, A. R.

AU - Blach, S.

AU - Chaudhry, A.

AU - Choi, M. S.

AU - Diab, T.

AU - Djauzi, S.

AU - El Khoury, S.

AU - Estes, C.

AU - Fakhry, S.

AU - Farooqi, J. I.

AU - Fridjonsdottir, H.

AU - Gani, R. A.

AU - Ghafoor Khan, A.

AU - Goldis, A.

AU - Gottfredsson, M.

AU - Gregorcic, S.

AU - Hajarizadeh, B.

AU - Han, K. H.

AU - Hasan, I.

AU - Hashim, A.

AU - Horvath, G.

AU - Hunyady, B.

AU - Husni, R.

AU - Jafri, W.

AU - Jeruma, A.

AU - Jonasson, J. G.

AU - Karlsdottir, B.

AU - Kim, D. Y.

AU - Kim, Y. S.

AU - Koutoubi, Z.

AU - Lesmana, L. A.

AU - Lim, Y. S.

AU - Löve, A.

AU - Maimets, M.

AU - Makara, M.

AU - Malekzadeh, R.

AU - Matičič, M.

AU - Memon, M. S.

AU - Merat, S.

AU - Mokhbat, J. E.

AU - Mourad, F. H.

AU - Muljono, D. H.

AU - Nawaz, A.

AU - Nugrahini, N.

AU - Priohutomo, S.

AU - Qureshi, H.

AU - Rassam, P.

AU - Razavi, H.

AU - Razavi-Shearer, D.

AU - Razavi-Shearer, K.

AU - Rozentale, B.

AU - Sadik, M.

AU - Saeed, K.

AU - Salamat, A.

AU - Salupere, R.

AU - Sanai, F. M.

AU - Sanityoso Sulaiman, A.

AU - Sayegh, R. A.

AU - Schmelzer, J. D.

AU - Sibley, A.

AU - Siddiq, M.

AU - Siddiqui, A. M.

AU - Sigmundsdottir, G.

AU - Sigurdardottir, B.

AU - Speiciene, D.

AU - Sulaiman, A.

AU - Sultan, M. A.

AU - Taha, M.

AU - Tarifi, H.

AU - Tayyab, G.

AU - Tolmane, I.

AU - Ud Din, M.

AU - Umar, M.

AU - Valantinas, J.

AU - Videčnik-Zorman, J.

AU - Yaghi, C.

AU - Yunihastuti, E.

AU - Yusuf, M. A.

AU - Zuberi, B. F.

AU - Gunter, J.

PY - 2015/12

Y1 - 2015/12

N2 - Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.

AB - Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.

KW - diagnosis

KW - disease burden

KW - epidemiology

KW - hepatitis C

KW - hepatitis C virus

KW - historical

KW - incidence

KW - mortality

KW - prevalence

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84945351461&partnerID=8YFLogxK

U2 - 10.1111/jvh.12475

DO - 10.1111/jvh.12475

M3 - Article

C2 - 26513445

AN - SCOPUS:84945351461

SN - 1352-0504

VL - 22

SP - 4

EP - 20

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

ER -

Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this